Triage and management of the pregnant hypertensive patient

Journal of Nurse-Midwifery

Volumn 44, Issue 6, 1999, Pages 558-571

  Kelley, Maureen A ^a   Kelley, Maureen ^a   Hodgson, Nell ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSIFICATION; EMERGENCY HEALTH SERVICE; FEMALE; HUMAN; HYPERTENSION; METHODOLOGY; MIDWIFE; MULTIMODALITY CANCER THERAPY; NURSING; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; RISK FACTOR;

COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTENSION; MIDWIFERY; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RISK FACTORS; TRIAGE;

EID: 0033218162     PISSN: 00912182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-2182(99)00109-3     Document Type: Review

References (77)

1. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America, and the Caribbean. Br J Obstet Gynecol 1992;99:547-57.
2. Berg CJ, Atrash MD, Koonin LM, Tucker M. Pregnancy-related mortality in the United States, 1987-1990. Obstet Gynecol 1996;88: 161-7.
3. Sibai BM, Gordon T, Thorn E, Caritas SN, Klebanoff M, McNellis D, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. Am J Obstet Gynecol 1995; 172:642-8.
4. Ros HS, Cnattingius S, Lipworth L. Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am J Epidemiol 1998; 147:1062-70.
5. Hypertensive disorders of pregnancy. In: Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC, Hankins GD, Clark S, editors. Williams obstetrics, 20th ed. Stamford, CT: Appleton & Lange, 1997.
6. Eskenazi, B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA 1991;266:237-41.
7. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Technical Bulletin No. 219. Washington (DC): ACOG, January 1996.
8. Villar MA, Sibai BM, Gonzalez AR, Emerson DP, Anderson GD. The clinical significance of elevated mean arterial blood pressure in the second trimester and a threshold increase in systolic and diastolic blood pressures during the third trimester. Am J Obstet Gynecol 1989;160:419-27.
9. Sawyer, MM. Diurnal and short-term variation of blood pressure: comparison of preeclamptic, chronic hypertensive and normotensive patients. Obstet Gynecol 1981;58:291-6.
10. Marx GF, Schwalbe SS, Cho E, Whitty JE. Automated blood pressure measurements in laboring women: are they reliable? Am J Obstet Gynecol 1993;168:796-8.
11. Meyer NL, Mercer BM, Friedman MD, Sibai BM. Urinary dipstick protein: a poor predictor of absent or severe proteinuria. Am J Obstet Gynecol 1994;170:137-41.
12. Chesley LC. Diagnosis of preeclampsia. Obstet Gynecol 1985; 65:423-30.
13. Blaustein DA, Kumar R, Goyzueta JD. Isolated proteinuria: diagnosis and evaluation. Prim Care Update Ob/Gyn 1995;6:204-6.
14. Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996;335:257-65.
15. Roberts JM, Redman CWG. Preeclampsia: more than pregnancy-induced hypertension. Lancet 1993;341:1447-8.
16. Higgins JR, Brennecke SP. Pre-eclampsia-still a disease of theories? Curr Opin Obstet Gynecol 1998; 10:129-33.
17. Levine RJ, Hauth JC, Curet LB, Sibai BM, Catalano PM, Morris CD, et al. Trial of calcium to prevent preeclampsia. N Engl J Med 1997;337:69-76.
18. Belizan JM, Villar J, Gonzalez L, Campondonico L, Bergel E. Calcium supplementation to prevent hypertensive disorders or pregnancy. N Engl J Med 1991;325:1399-1405.
19. Gant NF, Chand S, Whalley PJ, MacDonald PC. The nature of pressor responsiveness to angiotensin II in human pregnancy. Obstet Gynecol 1974;43:854-9.
20. Mitchell MD, Koenig JM. Increased production of 15-hydroxyeicosatetraenoic acid by placentae from pregnancies complicated by pregnancy-induced hypertension. Prostaglandins Leukot Essent Fatty Acids 1991;43:61-6.
21. Easterling TR, Benedetti TJ, Schmucker BC, Millard SP. Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gynecol 1990;76:1061-8.
22. Pritchard JA, Cunningham FG, Mason RA. Coagulation changes in eclampsia: their frequency and pathogenesis. Am J Obstet Gynecol 1976; 124:855-9.
23. Weinstein L. Preeclampsia-eclampsia with hemolysis, elevated liver enzymes, and thrombocytopenia. Obstet Gynecol 1985;66:657-70.
24. Barton JR, Sibai BM. Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 1993;168:599-604.
25. Cunningham FG, Fernandez CO, Hernandez C. Blindness associated with preeclampsia and eclampsia. Am J Obstet Gynecol 1995;172:1291-4.
26. Morriss MC, Twickler DM, Hatab MR, Clarke GD, Peshok RM, Cunningham FG. Cerebral blood flow and cranial magnetic resonance imaging in eclampsia and severe preeclampsia. Obstet Gynecol 1997; 89:561-8.
27. Brown JC, Veall N. The maternal placental blood flow in normotensive and hypertensive women. J Obstet Gynaecol Br Emp 1953; 60:141-6.
28. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Ann 1972;l:177-83.
29. Lowery CL Jr, Jenson BV, Wan J, Brumfield CG. A comparison between umbilical artery velocimetry and standard antepartum surveillance in hospitalized high-risk patients. Am J Obstet Gynecol 1990;162:710.
30. Anderson GD, Sibai BM. Hypertension in pregnancy. In: Gabbe SG, Niebyl, JR, Simpson JL, editors. Obstetrics: normal and problem pregnancies. New York: Churchill Livingstone, 1986.
31. Sibai BM. Eclampsia, 6. Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 1990; 163:1049-56.
32. Sibai BM, El-Nazer A, Gonzalez-Ruiz A. Severe preeclampsiaeclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 1986; 155: 1011-6.
33. Sibai BM, Mabie WC, Shamsa F, Villar MA, Anderson GD. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 1990; 162: 960-6.
34. Fay RA, Bronham DR, Brooks JA, Gebski VJ. Platelets and uric acid in the production of preeclampsia. Am J Obstet Gynecol 1985; 152:1038-9.
35. Lim KH, Friedman SA, Ecker JL, Kao L, Kilpatric SJ. Clinical utility of serum uric acid measurements in hypertensive diseases of pregnancy. Am J Obstet Gynecol 1998;178:1067-71.
36. Gilstrap LC, Cunningham FG, Whalley PJ. Management of pregnancy induced hypertension in the nulliparous patient remote from term. Semin Perinatol 1978-2:73-8.
37. Sibai BM, Gonzalez AR, Mabie WC, Moretti M. A comparison of labetalol plus hospitalization versus hospitalization versus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol 1987;70:323-30.
38. Sibai BM, Barton JR, Akl S, Sarinoglu C, Mercer BM. A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term. Am J Obstet Gynecol 1992; 167:879-84.
39. Matthews DD. A randomized controlled trial of bed rest and sedation or normal activity and non-sedation in the management of non-albuminuric hypertension in late pregnancy. Br J Obstet Gynaecol 1977;84:108-14.
40. Tuffnell DJ, Lilford RJ, Buchan PC, Prendiville VM, Tuffnell AJ, Holgate P, et al. Randomized controlled trial of day care for hypertension in pregnancy. Lancet 1992;339:224-9.
41. Crowther CA, Bouwmeester AM, Ashurst HM. Does admission to hospital for bed rest prevent disease progression or improve fetal outcome in pregnancy complicated by non-proteinuric hypertension? Br J Obstet Gynaecol 1992;99:13-7.
42. Goldenberg RL, Cliver SP, Bronstein J, Cutter GR, Andrews WW, Mennemeyer ST. Bed rest in pregnancy. Obstet Gynecol 1994; 84:131-6.
43. Belizàn JM, Villar J, Gonzalez L, Campodonico L, Bergel E. Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 1991;325:1399-1405.
44. Bucher HC, Guyatt GH, Cook RJ. Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. JAMA 1996;275: 1113-7.
45. Levine RJ, Hauth JC, Curet LB, Sibai BM, Catalano PM, Morris CD, et al. Trial of calcium to prevent preeclampsia. N Engl J Med 1997;337:69-75.
46. Herrera JA, Arevalo-Herrera M, Herrera S. Prevention of preeclampsia by linoleic acid and calcium supplementation: a randomized controlled trial. Obstet Gynecol 1998;91:585-90.
47. Schiff E, Peleg E, Goldenberg M. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989;321:351-6.
48. Hauth JC, Goldenberg, RL, Parker CR Jr, Philips JB III, Cooper RL, DuBard MB, et al. Low-dose aspirin therapy to prevent preeclampsia. Am J Obstet Gynecol 1993; 168:1083-93.
49. Uzan S, Beaufils M, Breat G, Bazin B, Capitant C, Paris J. Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial. Lancet 1991;337:1427-31.
50. Sibai BM, Caritis SN, Thorn E, Klebanoff M, McNellis D, Rocco L, et al. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine units: prevention of preeclampsia with low-dose aspirin in healthy nulliparous pregnant women. N Engl J Med 1993;329:1213-8.
51. ECPPA (Estudo colaborativo para prevencao da pre-eclampsia com aspirina) Collaborative Group. ECPPA: randomised trial of low dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994;343:619-29.
52. CLASP: Collaborative Low-dose Aspirin Study in Pregnancy Colaborative Group. A randomized trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women. Lancet 1994;343:619.
53. Caritis S, Sibai B, Hauth J, Lindheimer M, Klebanoff M, Thom E, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med 1998;338:701-5.
54. Witlin AG, Sibai BM. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol 1998;92:883-8.
55. Sibai BM, Mercer BM, Schiff E, Friedman SA. Agrressive versus expectant management of severe preeclampsia at 28-32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 1994; 171:818-22.
56. Sibai BM, Taslimi M, Abdella TN, Brooks TF, Spinnato JA, Anderson GD. Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester. Am J Obstet Gynecol 1985; 152:32-7.
57. Mabie WC, Gonzalez AR, Sibai BM, Amon E. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol 1987;70:328.
58. Douglas KA, Redman CWG. Eclampsia in the United Kingdom. BMJ 1994;309:1395-1400.
59. Egerman RS, Sibai BM. Recognizing and managing HELLP syndrome and its imitators. Contemp OB/GYN Oct 1997 p: 129-49.
60. Sibai BM, Taslimi MM, El-Nazer A. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986;155:501-8.
61. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993; 169:1000-6.
62. Magann EF, Bass D, Chauhan SP, Sullivan DL, Martin RW, Martin JN. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994;171:1148-53.
63. Anderson GD. A systematic approach to eclamptic convulsion. Contemp OB/GYN 1987;March:65-70.
64. Ladewig PW, London ML, Olds SB. Maternal-newborn nursing care, 4th ed. Menlo Park, CA: Addison Wesley, 1998.
65. Xenakis, EM, Piper JM, Field N, Conway D, Langer O. Preeclampsia: is induction of labor more successful? Obstet Gynecol 1997;89:600-3.
66. Moore TR, Key TC, Reisner LS, Resnik R. Evaluation of the use of continuous lumbar epidural anesthesia for hypertensive pregnant women in labor. Am J Obstet Gynecol 1985;152(4):404-12.
67. Sipes SL, Weiner CP, Gellhaus TM, Goodspeed JD. Effects of magnesium sulfate infusion upon plasma prostaglandins in preeclampsia and preterm labor. Hypertens Pregnancy 1994; 13:293-302.
68. Belfort MA, Moise KJ. Effect of magnesium sulfate on maternal blood flow in preeclampsia: a randomized, placebo-controlled study. Am J Obstet Gynecol 1992; 167:661-6.
69. Atkinson MW, Guinn D, Owen J, Hauth JC. Does magnesium sulfate affect the length of labor induction in women with pregnancyassociated hypertension? Am J Obstet Gynecol 1995;173(4):1219-22.
70. Witlin AG, Friedman SA, Sibai BM. The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol 1997; 176:623-7.
71. Atkinson MW, Belfort MA, Saade GR, Moise KJ. The relation between magnesium sulfate therapy and fetal heart rate variability. Obstet Gynecol 1994;83:967-70.
72. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995;345:1455-63.
73. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995;333:201-5.
74. National High Blood Pressure Education Program Working Group report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990;163:1691-1712.
75. Sibai BM. Diagnosis and management of chronic hypertension in pregnancy. Obstet Gynecol 1991;78:451-61.
76. Sibai BM, Abdella TN, Anderson GD. Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol 1983; 61:571-6.
77. Eskenazi B, Fenster L, Sidney S, Elkin EP. Fetal growth retardation in infants of multiparous and nulliparous women with preeclampsia. Am J Obstet Gynecol 1993; 169:1112-8.